out epigenetic reprogramming that occurs postfertilization (29, 30) . It is noteworthy that 63 of the 72 C-DMRs overlap with regions previously shown to have altered methylation patterns in methylation enzyme mutants (Fig. 4) (3) . Of the 14 C-DMRs that overlap with genes, 5 become reexpressed in met1-3 and 1 transcript becomes silenced in rdd (3). These results suggest that a failure to faithfully maintain genome-wide methylation patterns by MET1 and/or RDD is likely one source of spontaneous epiallele formation.
Regardless of their origin, the majority of epialleles identified in this study are meiotically stable and heritable across many generations in this population. Understanding the basis for such transgenerational instability and the mechanism(s) that trigger and/or release these epiallelic states will be of great importance for future studies. and R. Amasino for discussions; R. Shaw The manipulation of protein backbone structure to control interaction and function is a challenge for protein engineering. We integrated computational design with experimental selection for grafting the backbone and side chains of a two-segment HIV gp120 epitope, targeted by the cross-neutralizing antibody b12, onto an unrelated scaffold protein. The final scaffolds bound b12 with high specificity and with affinity similar to that of gp120, and crystallographic analysis of a scaffold bound to b12 revealed high structural mimicry of the gp120-b12 complex structure. The method can be generalized to design other functional proteins through backbone grafting.
C omputational protein design tests our understanding of protein structure and folding and provides valuable reagents for biomedical and biochemical research; longterm goals include the design of field-or clinicready biosensors (1), enzymes (2), therapeutics (3), and vaccines (4, 5) . A major limitation has been an inability to manipulate backbone structure; most computational protein design has involved sequence design on predetermined backbone structures or with minor backbone movement (1) (2) (3) (4) (5) . Accurate backbone remodeling presents a substantial challenge for computational methods owing to limited conformational sampling and imperfect energy functions (6).
Novel recognition modules (7), inhibitors (8, 9) , enzymes (2), and immunogens (4, 5, 10, 11) have been designed by grafting functional constellations of side chains onto protein scaffolds of predefined backbone structure. In all cases, the restriction to using predetermined scaffold backbone structures limited the complexity of the functional motifs that could be transplanted. For example, the de novo enzymes could accommodate grafting of only three or four catalytic groups, whereas many natural enzymes have six or more (12) , and the immunogens were limited to continuous (single-segment) epitopes even though most antibody epitopes are discontinuous (involving two or more antigen segments) (13, 14) .
To address the challenge of incorporating backbone flexibility modeling into grafting design, we developed a hybrid computational-experimental method for grafting the backbone and side chains of functional motifs onto scaffolds (Fig. 1) . We tested this method by grafting a discontinuous HIV gp120 epitope, targeted by the broadly neutralizing monoclonal antibody b12 (15) , onto an unrelated scaffold. b12 binds to a conserved epitope within the CD4-binding site (CD4bs) of gp120 (16) , an area of great interest for vaccine design. We focused on transplantation of two segments from gp120: residues 365 to 372, known as the CD4b (CD4 binding) loop (17) , and residues 472 to 476, known as the ODe (outer domain exit) loop (16) . The b12-gp120 interaction involves six or seven backbone segments on gp120 (16) , but 60% of the buried surface area on gp120 lies on the CD4b and ODe loops, and a Rosetta energy calculation (18) suggested that these two segments could account for up to 80% of the binding energy.
The work flow ( Fig. 1 ) has four stages: (i) scaffold search, in which the Protein Data Bank (PDB) (19) is searched for scaffolds suitable to accept the backbone segments comprising the motif; (ii) scaffold design, in which the motif backbone segments replace native scaffold backbone and new connecting segments and surrounding side chains are built to support the motif conformation; (iii) computation-guided library design, in which a small set of mutagenesis libraries for sequential screening are derived from an ensemble of designs with expanded structural and compositional diversity in the connecting segments; and (iv) in vitro screening, in which computationguided libraries are screened to identify clones with optimal functional activity.
For scaffold search, we developed an algorithm (Multigraft Match) that exhaustively searched a culled PDB for suitable scaffolds. For all possible combinations of four insert positions in every scaffold, Multigraft Match produced a low-resolution prediction of whether the epitope backbone segments could be grafted onto the scaffold while maintaining backbone continuity and avoiding steric clash ( fig. S1 ). Eleven scaffolds satisfied the geometrical and steric clash requirements and were selected for design (table S1) .
For scaffold design, we developed an algorithm (Multigraft Design) that, given a preliminary rigid-body orientation for a discontinuous epitope relative to a scaffold, deleted appropriate regions of the scaffold, built new segments to connect the epitope to the scaffold, and designed side chains neighboring the epitope and connecting segments to support the graft ( fig. S2 ). This involved aggressive structural manipulations, including replacement of ordered secondary structure motifs by the epitope segments, flexible backbone modeling of two or more connecting segments, and sequence design of 10 or more core residues. Several design variants of each candidate scaffold ( fig. S3) Fig. 1 . Combined in silico-in vitro strategy for the transplantation of complex structural motifs to heterologous scaffold proteins. The diagrams illustrate the stages in the design of a non-HIV scaffold presenting two loops from the b12 epitope on HIV gp120. Table 1 . Affinity and kinetics of the interaction between recombinant 2bodx variants and b12. For all the reported values, the standard error is ≤ T7 of the last significant digit. RL, random library; L1, library 1; L2, library 2; L3, library 3. k on and k off represent the kinetic association and dissociation rates, respectively, of the measured interactions. (table S1 ). Purified designs were tested for b12 binding by surface plasmon resonance (SPR). One design, 2bodx_03, which had 39 mutations and 11 deletions relative to the parent protein ( fig. S4 ), bound to b12 weakly (dissociation constant K D ≈ 300 mM). The binding was specific, because no binding was detected for the epitope mutant Asp 114 → Arg (D114R) (20) (fig. S5) . A highresolution (1.3 Å) crystal structure of 2bodx_03 showed no discernible electron density for the epitope or connecting segments ( fig. S5 and table S2), indicating that these regions were flexible in solution. In an initial attempt to optimize the b12 affinity of 2bodx_03, a whole-protein random mutagenesis library was screened by yeast display (21) . Clone 2bodx_R3 was thereby isolated with two mutations [Ser 177 → Gly (S177G) and Ala 118 → Val (A118V)] from 2bodx_03 and a factor of 10 higher affinity for b12 (K D ≈ 30 mM) ( Table 1, Fig. 2, and fig. S6 ). This interaction remained three orders of magnitude weaker than gp120-b12 interaction [K D = 20 nM (16)]. The low affinity was likely due to nonoptimal sequences and conformations in the connecting segments. Optimization by targeted random mutagenesis and in vitro screening was not feasible because allowing 20 amino acids at all 21 positions judged to be important in the connecting segments would yield impractical library sizes of 2 × 10 27 .
2bodx variant Origin b12 interaction parameters (SPR)
In computation-guided library design, we used a structure-sequence diversification protocol ( fig. S7 ) to devise relatively small libraries based on more complete sampling of low-energy structures and sequences in the connecting segments. For each connecting segment, 20,000 backbone conformations were separately generated and subjected to sequence design while keeping the rest of the 2bodx_03 structure fixed. Several lowenergy models for each segment were exhaustively recombined in silico and subjected to further sequence design to identify 2bodx models with optimal structures and sequences in all connecting segments. After a final round of conformational resampling and design ( fig. S7 ), the best 45 models by several Rosetta metrics (18) were used to generate sequence profiles to identify the amino acids that occurred at each of the 21 positions in the connecting segments ( fig. S8 ). The diversity was reduced by eliminating residues that occurred at low frequency, that were similar in size and chemical nature to more frequent residues, or that were judged likely to bury a polar side chain. The final library allowed mutations at 21 positions and had a theoretical size of 10 12 .
For in vitro screening, we used yeast display. To overcome the limitations of the library size supported by yeast display ( 10 7 ), we constructed two partially overlapping sublibraries and screened them sequentially (figs. S9 and S10). The first sublibrary (library 1) contained all (4 × 10 6 ) of the computationally designed ODe loop connecting segments combined with eight design variants of the CD4b loop connecting segments present in 23 of the 45 models. After three rounds of screening, the selected ODe loop variants (from at least 18 different clones) were combined with all (2 × 10 5 ) of the computationally designed CD4b loop variants to create library 2. This sublibrary was screened for three rounds to isolate clone 2bodx_42, which differed from 2bodx_03 by 17 mutations (fig. S11 ). Recombinant 2bodx_42 bound b12 with a K D of 166 nM, an improvement by a factor of >1800 over 2bodx_03 (Table 1) . Introducing the A118V mutation from 2bodx_R3 further increased b12 affinity, as the resulting variant (2bodx_43) bound b12 with a K D of 33 nM (Table 1, Fig. 2, and fig. S6 ), within a factor of 2 of the b12-gp120 affinity (16) . Introducing the D114R mutation on 2bodx_43 resulted in loss of detectable b12 binding ( fig. S12) , demonstrating that the binding was specific to the epitope. Further, 2bodx_43 was thermally stable (melting point = 75°C) and monomeric in solution ( fig. S13) .
To assess whether the b12 affinity could be improved further and to evaluate if the computation- (Table 1 and fig. S9 ). (C) 2bodx_43 binds to b12, but not to CD4 or other antibodies that target the CD4bs on gp120. guided libraries restricted the sequence space effectively, we screened a third library based on 2bodx_43 with expanded sampling at seven positions ( fig. S10 ). The highest-affinity clone isolated (2bodx_45) differed from 2bodx_43 by two mutations ( fig. S4 ) and bound b12 with a K D of 10 nM, a factor of 3 better than 2bodx_43 and as tightly as gp120 (16) (Table 1, Fig. 2,  and fig S6) . Another high-affinity variant selected from this library (2bodx_44, K D = 19 nM, fig. S6 ) was used to investigate the b12 binding contributions of library-selected mutations. We measured the b12 binding of 2bodx_44 constructs in which the "evolved" residues were individually reverted to their 2bodx_03 identity. Only 6 of 16 reversions reduced the b12 affinity of 2bodx_44 by a factor of 3 or more, and a 2bodx_03 variant that contained nine of the 2bodx_44 mutations had only micromolar affinity for b12 (K D = 1.5 mM) ( fig. S14) . Thus, the selected mutations made synergistic contributions to the high b12 affinity of 2bodx constructs.
To evaluate the degree to which the 2bodx-b12 interaction recapitulated the gp120-b12 interaction, we solved a crystal structure for 2bodx_43 complexed with b12 at 2.07 Å resolution ( Fig.  3A and table S2 ). Comparison with the gp120-b12 complex (16) revealed a high degree of mimicry; superposition of the epitope and paratope of both complexes gave an overall backbone root mean square deviation (RMSD) of 0.71 Å (Fig.  3 , B and C) (22 , and Tyr 100h were recapitulated in the 2bodx_43-b12 complex (Fig. 3C and tables S3 and S4) . The total buried areas in the complexes were also similar, except for a small additional area on the scaffold outside the epitope (fig. S15) .
The CD4bs is a major antibody target in HIV infection (23) . Reagents are desired that bind b12 but not CD4bs-directed non-neutralizing antibodies (24) such as b13 that engages gp120 similarly to b12 (25) . Of eight CD4bs-directed antibodies tested, 2bodx_43 bound tightly to b12 only (Fig. 2C) . Additional SPR analyses showed that 2bodx_43 binds more tightly to b12 than to b13 by a factor of >10,000 ( fig. S16) (26) . These results indicate that b12 epitope-scaffolds are promising tools for HIV vaccine research and encourage the application of backbone grafting to engineer antigens, enzymes, and inhibitors.
